{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:58:17Z","timestamp":1767844697583,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126387","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T11:53:02Z","timestamp":1727351582000},"page":"126387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A population database analysis to estimate the varicella vaccine effectiveness in children\u00a0&lt;\u00a014 years in a high vaccination coverage area from 2004 to 2022"],"prefix":"10.1016","volume":"42","author":[{"given":"Elisa","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Cocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Scamarcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Cantarutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Dona'","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126387_bb0005","series-title":"Le novit\u00e0 del decreto legge sui vaccini","author":"Ministro della Salute","year":"2017"},{"key":"10.1016\/j.vaccine.2024.126387_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.91.1.17","article-title":"Modified chickenpox in children immunized with the Oka\/Merck varicella vaccine","volume":"91","author":"Watson","year":"1993","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126387_bb0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajic.2017.07.029","article-title":"Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: results from a meta-analysis","volume":"46","author":"Zhu","year":"2017","journal-title":"Am J Infect Control"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2024.126387_bb0025","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126387_bb0030","first-page":"2651","article-title":"Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: results from five east European countries","volume":"2643","author":"Prymula","year":"2021","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126387_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095419","article-title":"Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases?","volume":"9","author":"Gini","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126387_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.36153","article-title":"Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012","volume":"11","author":"Tafuri","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126387_bb0045","series-title":"US- CDC","year":"2024"},{"key":"10.1016\/j.vaccine.2024.126387_bb0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B Methodol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2024.126387_bb0055","first-page":"162","article-title":"Update and review of the 2011 Italian deprivation index calculated at the census section level","volume":"44","author":"Rosano","year":"2020","journal-title":"Epidemiol Prev"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126387_bb0060","article-title":"The association between pediatric COVID-19 vaccination and socioeconomic position: nested case-control study from the Pedianet Veneto cohort","volume":"1","author":"Batzella","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126387_bb0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/14760584.2017.1381020","article-title":"Socioeconomic differences in childhood vaccination in developed countries: a systematic review of quantitative studies","volume":"16","author":"Bocquier","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.126387_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126387_bb0075","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1186\/s12889-023-16304-4","article-title":"The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study","volume":"23","author":"Qiu","year":"2023","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126387_bb0085","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cjca.2021.05.009","article-title":"Challenges and lessons learned from COVID-19 trials: should we be doing clinical trials differently?","volume":"37","author":"Janiaud","year":"2021","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126387_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2407","article-title":"Clinical efficacy and effectiveness of alternative varicella vaccination strategies: an overview of reviews","volume":"33","author":"Ahern","year":"2023","journal-title":"Rev Med Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126387_bb0095","article-title":"Vaccines for measles, mumps, rubella, and varicella in children","volume":"2021","author":"Di Pietrantonj","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126387_bb0100","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.126387_bb0105","series-title":"New Zealand National Health Committee. Varicella and Rotavirus Vaccination in New Zealand - Assessment Reports. New Zealand National Health Committee (NHC)","year":"2012"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126387_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.32385\/rpmgf.v28i2.10928","article-title":"Vacina da varicela na inf\u00e2ncia [chickenpox vaccine in childhood]","volume":"28","author":"Garrido","year":"2012","journal-title":"Revista Portuguesa de Medicina Geral e Familiar"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126387_bb0115","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/vaccines11101567","article-title":"Real-world effectiveness of the varicella vaccine among children and adolescents in qatar: a case\u2013control study","volume":"11","author":"Bibi","year":"2023","journal-title":"Vaccines"},{"issue":"Supplement_4","key":"10.1016\/j.vaccine.2024.126387_bb0120","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiac299","article-title":"The effectiveness of varicella vaccine: 25 years of Postlicensure experience in the United States","volume":"226","author":"Shapiro","year":"2022","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126387_bb0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14760584.2018.1433999","article-title":"Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination:a meta-analysis [published correction appears in expert rev vaccines. 2018 Jun;17(6):563]","volume":"17","author":"Yin","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126387_bb0130","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.vaccine.2024.02.002","article-title":"Effectiveness of the combined MMRV Priorix-tetra\u2122 vaccine against varicella in a large Italian region: a case-control study","volume":"42","author":"Fortunato","year":"2024","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:42:27Z","timestamp":1741887747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":24,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010697"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126387","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A population database analysis to estimate the varicella vaccine effectiveness in children\u00a0<\u00a014 years in a high vaccination coverage area from 2004 to 2022","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126387"}}